SPAC Market Outlook Through 2019
- SPACs continue to be an attractive vehicle for raising capital.
- Market interest remains strong, with IPO Vital Signs reporting 12 SPAC IPOs raising over $2.3 billion by Q3 2018.
- Tech, Biotech and Healthcare companies continue to be prime targets, but for how long?
- Understanding costs – granting SPAC equity versus paying investment banking fees for traditional IPOs.